Federal Watchdog Agency Says Drug Scheduling Process Has 'Gaps' As DEA's Marijuana Review Continues...

Wed, Sep 23

Perspectives

A new Government Accountability Office report concluded that federal agencies' policies that govern the drug scheduling process have "gaps" that "may pose a risk"—a finding that comes as the Drug Enforcement Administration is considering broadly rescheduling marijuana. "DEA does

1928

A new federal watchdog report is calling on agencies to improve their policies that govern the drug scheduling process—including how they evaluate substances and develop recommendations. The new U.S....

Discover